COPD, emphysema and the onset of lung cancer. A systematic review

Cancer Letters

Volumn 382, Issue 2, 2016, Pages 240-244

  Mouronte Roibás, Cecilia ^a   Leiro Fernández, Virginia ^a   Fernández Villar, Alberto ^a   Botana Rial, Maribel ^a   Ramos Hernández, Cristina ^a   Ruano Ravina, Alberto ^b,c  

^a Alvaro Cunqueiro Hospital   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

COPD; Emphysema; Lung cancer

Indexed keywords

AIRWAY OBSTRUCTION; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; HUMAN; LUNG CANCER; LUNG EMPHYSEMA; PREVALENCE; PRIORITY JOURNAL; SHORT SURVEY; SMOKING; SPIROMETRY; SYSTEMATIC REVIEW; ADVERSE EFFECTS; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; LUNG; LUNG NEOPLASMS; ODDS RATIO; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVENTION AND CONTROL; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION;

EARLY DIAGNOSIS; HUMANS; LUNG; LUNG NEOPLASMS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; SPIROMETRY;

EID: 84989356237     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2016.09.002     Document Type: Review

References (33)

1. [1] Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136 (2015), E359–E386.
2. [2] Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics. CA Cancer J. Clin 61 (2011), 69–90.
3. [3] Miravitlles, M., Soler-Cataluña, J.J., Calle, M., Molina, J., Almagro, P., Quintano, J.A., et al. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery. Arch. Bronconeumol 48 (2012), 247–257.
4. [4] Peto, R., Lopez, A.D., Boreham, J., Thun, M., Heath, C., Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 339 (1992), 1268–1278.
5. [5] Durham, A.L., Adcock, I.M., The relationship between COPD and lung cancer. Lung Cancer 90 (2015), 121–127.
6. [6] Wang, Z., Association between chronic obstructive pulmonary disease and lung cancer: the missing link. Chin. Med. J. 126 (2013), 154–165.
7. [7] Young, R.P., Hopkins, R.J., Christmas, T., Black, P.N., Metcalf, P., Gamble, G.D., COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur. Respir. J. 34 (2009), 380–386.
8. [8] Wasswa-Kintu, S., Gan, W.Q., Man, S.F.P., Pare, P.D., Sin, D.D., Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 60 (2005), 570–575.
9. [9] Hashimoto, N., Matsuzaki, A., Okada, Y., Imai, N., Iwano, S., Wakai, K., et al. Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients. BMC Pulm. Med, 14, 2014, 14.
10. [10] Li, Y., Swensen, S.J., Karabekmez, L.G., Marks, R.S., Stoddard, S.M., Jiang, R., et al. Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment. Cancer Prev. Res. (Phila) 4 (2011), 43–50.
11. [11] Smith, B.M., Pinto, L., Ezer, N., Sverzellati, N., Muro, S., Schwartzman, K., Emphysema detected on computed tomography and risk of lung cancer: a systematic review and meta-analysis. Lung Cancer 77 (2012), 58–63.
12. [12] De Torres, J.P., Bastarrika, G., Wisnivesky, J.P., Alcaide, A.B., Campo, A., Seijo, L.M., et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 132 (2007), 1932–1938.
13. [13] Wilson, D.O., Weissfeld, J.L., Balkan, A., Schragin, J.G., Fuhrman, C.R., Fisher, S.N., et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am. J. Respir. Crit. Care Med 178 (2008), 738–744.
14. [14] Maldonado, F., Bartholmai, B.J., Swensen, S.J., Midthun, D.E., Decker, P.A., Jett, J.R., Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest 138 (2010), 1295–1302.
15. [15] Henschke, C.I., Yip, R., Boffetta, P., Markowitz, S., Miller, A., Hanaoka, T., et al. CT screening for lung cancer: importance of emphysema for never smokers and smokers. Lung Cancer 88 (2015), 42–47.
16. [16] Abal Arca, J., Parente Lamelas, I., Almazán Ortega, R., Blanco Pérez, J., Toubes Navarro, M.E., Marcos Velázquez, P., Lung cancer and COPD: a common combination. Arch. Bronconeumol 45 (2009), 502–507.
17. [17] Sanchez-Salcedo, P., Berto, J., de Torres, J.P., Campo, A., Alcaide, A.B., Bastarrika, G., et al. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP). Arch. Bronconeumol 51 (2015), 169–176.
18. [18] Hohberger, L.A., Schroeder, D.R., Bartholmai, B.J., Yang, P., Wendt, C.H., Bitterman, P.B., et al. Correlation of regional emphysema and lung cancer: a lung tissue research consortium-based study. J. Thorac. Oncol 9 (2014), 639–645.
19. [19] de Torres, J.P., Casanova, C., Marín, J.M., Zagaceta, J., Alcaide, A.B., Seijo, L.M., et al. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study. Respir. Med 107 (2013), 702–707.
20. [20] de Torres, J.P., Wilson, D.O., Sanchez-Salcedo, P., Weissfeld, J.L., Berto, J., Campo, A., et al. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score. Am. J. Respir. Crit. Care Med 191 (2015), 285–291.
21. [21] De Torres, J.P., Marín, J.M., Casanova, C., Cote, C., Carrizo, S., Cordoba-Lanus, E., et al. Lung cancer in patients with chronic obstructive pulmonary disease – incidence and predicting factors. Am. J. Respir. Crit. Care Med 184 (2011), 913–919.
22. [22] Sekine, Y., Fujisawa, T., Suzuki, K., Tsutatani, S., Kubota, K., Ikegami, H., et al. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group. Respirology 19 (2014), 98–104.
23. [23] Sanchez-Salcedo, P., Wilson, D.O., de Torres, J.P., Weissfeld, J.L., Berto, J., Campo, A., et al. Improving selection criteria for lung cancer screening. The potential role of emphysema. Am. J. Respir. Crit. Care Med 191 (2015), 924–931.
24. [24] Loganathan, R.S., Stover, D.E., Shi, W., Venkatraman, E., Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 129 (2006), 1305–1312.
25. [25] Congleton, J., Muers, M.F., The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respir. Med 89 (1995), 291–296.
26. [26] Mannino, D.M., Aguayo, S.M., Petty, T.L., Redd, S.C., Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch. Intern. Med 163 (2003), 1475–1480.
27. [27] Luo, J., Solimini, N.L., Elledge, S.J., Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136 (2009), 823–837.
28. [28] Negrini, S., Gorgoulis, V.G., Halazonetis, T.D., Genomic instability – an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol 11 (2010), 220–228.
29. [29] Agusti, A., Sin, D.D., Biomarkers in COPD. Clin. Chest Med 35 (2014), 131–141.
30. [30] Faner, R., Tal-Singer, R., Riley, J.H., Celli, B., Vestbo, J., MacNee, W., et al. Lessons from ECLIPSE: a review of COPD biomarkers. Thorax 69 (2014), 666–672.
31. [31] Parimon, T., Chien, J.W., Bryson, C.L., McDonell, M.B., Udris, E.M., Au, D.H., Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med 175 (2007), 712–719.
32. [32] Torres-Durán, M., Ruano-Ravina, A., Kelsey, K.T., Parente-Lamelas, I., Provencio, M., Leiro-Fernández, V., et al. Small cell lung cancer in never-smokers. Eur. Respir. J. 47 (2016), 947–953.
33. [33] Brenner, D.R., Boffetta, P., Duell, E.J., Bickeböller, H., Rosenberger, A., McCormack, V., et al. Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am. J. Epidemiol 176 (2012), 573–585.